Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoantigen‐based cancer vaccination using chimeric RNA‐loaded dendritic cell‐derived extracellular vesicles
Xiao Xiong, Xiurong Ke, Lu Wang, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 468
The role of extracellular vesicles in cancer
Raghu Kalluri, Kathleen M. McAndrews
Cell (2023) Vol. 186, Iss. 8, pp. 1610-1626
Closed Access | Times Cited: 298
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Heng Dong, Qiang Li, Yu Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 48
Roles of exosomes in immunotherapy for solid cancers
C. Lyu, Haifeng Sun, Zhenqiang Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 39
Exosome-Based Carrier for RNA Delivery: Progress and Challenges
Yicheng Lu, Wei Huang, Meng Li, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 598-598
Open Access | Times Cited: 40
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29
An iPSC-derived exosome-pulsed dendritic cell vaccine boosts antitumor immunity in melanoma
Ronghao Wang, Tianchuan Zhu, Bingzong Hou, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2376-2390
Open Access | Times Cited: 24
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri
ACS Nano (2025)
Closed Access | Times Cited: 1
Extracellular vesicle-mediated communication between CD8+ cytotoxic T cells and tumor cells
Zeyu Huang, Xuehui Liu, Qinghao Guo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation
Juwita N. Rahmat, Jiayi Liu, Taili Chen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5862-5903
Open Access | Times Cited: 7
Targeting PAK4 reverses cisplatin resistance in NSCLC by modulating ER stress
Shixin Liu, Pingshan Yang, Lu Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine
Xingli Dong, Yusheng Lin, Kai Li, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Open Access | Times Cited: 6
Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 5
Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome
Ana María Bolívar, Fahriye Düzağaç, Krishna M. Sinha, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101204-101204
Open Access | Times Cited: 12
Chimerism: A whole new perspective in gene regulation
Gayatri G Chitale, Swati Kulkarni, Sharmila A. Bapat
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130767-130767
Closed Access
Progress of extracellular vesicles-based system for tumor therapy
Fei Wang, Le Yin, Yong Hu
Journal of Controlled Release (2025)
Closed Access
Engineered dendritic cells-derived extracellular vesicles for cancer immunotherapy
Miguel Coelho, Sofia Torres Quintas, Bruno Sarmento, et al.
Journal of Controlled Release (2025), pp. 113620-113620
Closed Access
Bioinspired Membrane‐Based Cancer Vaccines for Immunotherapy: Progress and Perspectives
Ying Miao, Jianlin Ge, Longyi Zheng, et al.
Small (2025)
Closed Access
Genetically engineered cell-derived nanovesicles for cancer immunotherapy
Yang Zi, Zongmin Zhao
Nanoscale (2024) Vol. 16, Iss. 17, pp. 8317-8334
Closed Access | Times Cited: 3
Oncogenic SLC2A11–MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability
Liang Cheng, Chenwei Yang, Junlin Lu, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 3
Engineered extracellular vesicles as a next-generation vaccine platform
Mei Lu, Haonan Xing, Xiaoyun Zhao, et al.
Matter (2024) Vol. 7, Iss. 12, pp. 4180-4205
Closed Access | Times Cited: 3
Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, et al.
Advanced Therapeutics (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 8
Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy
Qiujun Zhou, Yan Yan, Yuanyan Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113790-113790
Open Access | Times Cited: 14
PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET
Hongmei Dong, Wan‐Wan Lin, Liang Du, et al.
Cancer Letters (2023) Vol. 567, pp. 216283-216283
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top